Posts Tagged ‘pfe’

While declining sales & earnings are likely to capture the headlines, we expect Pfizer to post second quarter results that are slightly ahead of Wall Street’s estimates.

We believe that the cost cutting measures that Pfizer has undertaken could produce better than expected first quarter earnings.